Efficacy and safety of darolutamide in Black/African–American patients from the phase III ARAMIS study

Overview of attention for article published in Future Oncology, February 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 1,224 followers.

New data published from the phase 3 ARAMIS study focused on the Black/African–American patients with #nmCRPC in @FutureOncol_FSG https://t.co/s863PdlAmk #ProstateCancer

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.